Cargando…
ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
BACKGROUND: Thyroid cancer is the most common malignant endocrine tumour, and metastasis has become the main reason for treatment failure. However, the underlying molecular mechanism of thyroid cancer metastasis remains poorly understood. We investigated the role of the tumour suppressor zinc finger...
Autores principales: | Zhang, Yankun, Sun, Min, Gao, Lifen, Liang, Xiaohong, Ma, Chunhong, Lu, Jinghui, Yue, Xuetian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840030/ https://www.ncbi.nlm.nih.gov/pubmed/35151335 http://dx.doi.org/10.1186/s12935-022-02499-w |
Ejemplares similares
-
Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
por: Ding, Lu, et al.
Publicado: (2023) -
Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019) -
ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
por: Ma, Hongxin, et al.
Publicado: (2014) -
ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
por: Zhang, Yankun, et al.
Publicado: (2023) -
Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
por: Tan, Siyu, et al.
Publicado: (2021)